EMA-raadpleging: richtlijn voor klinisch onderzoek van geneesmiddelen voor de behandeling van jicht
The European Medicines Agency has released for public consultation a guideline on clinical investigation of medicinal products for the treatment of gout.
The main aim of the guideline is to address general guidance on the development of medicinal products for the treatment of gout. This guideline should be read in conjunction with other EMA and ICH guidelines, which may apply to these conditions and patient populations.
The draft paper is available by clicking here.
Comments should be provided using this template and sent to R-IWP@ema.europa.eu by 8 August 2019.
Please note that EMA may collect and further process some personal data of stakeholders and interested parties who submit contributions to the consultations. For more information, see Specific privacy statement for public consultations.
For more information on the European regulatory system for medicines, please click here (brochure available in all languages).
You have received this mail because you have registered in the EMA stakeholders database and subscribed to receive this kind of information. However, if you no longer wish to receive such communications from us, please send an email to StakeholdersDB@ema.europa.euto unsubscribe.